NA
OM icon

NewEdge Advisors’s Outset Medical OM Stock Holding History

NewEdge Advisors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-250
Closed -$4.8K – 4210
2025
Q2 		$4.8K Buy
+250
New +$3.9K ﹤0.01% 3420
2024
Q2 		– Sell
-4
Closed -$132 – 3946
2024
Q1 		$132 Sell
4
-1
-20% -$51 ﹤0.01% 3694
2023
Q4 		$400 Buy
+5
New +$407 ﹤0.01% 3553
2023
Q1 		– Sell
-1
Closed -$387 – 3919
2022
Q4 		$387 Buy
+1
New +$282 ﹤0.01% 3213

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

NewEdge Advisors's OM Position: Q3 2025 in Review

NewEdge Advisors sold out of Outset Medical (OM) in Q3 2025, closing a stake of 250 shares — an estimated $4.8K sold.

NewEdge Advisors first reported a position in OM in Q4 2022 and held it in 4 quarters. The position peaked at $4.8K in Q2 2025. 101 funds tracked by Wall St. Rank hold OM as of Q3 2025.

  • NewEdge Advisors reported no remaining Outset Medical position as of Q3 2025 after selling out during the quarter.
  • NewEdge Advisors sold 250 Outset Medical shares in Q3 2025, an estimated $4.8K.
  • NewEdge Advisors first reported a position in Outset Medical in Q4 2022 and held it in 4 quarters.
  • NewEdge Advisors's Outset Medical position peaked at $4.8K in Q2 2025.
  • 101 funds tracked by Wall St. Rank held Outset Medical as of Q3 2025.

Based on NewEdge Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.